**Abstract**

**Introduction:** Previous ^1^H-MRS studies on schizophrenia reported the abnormal concentration of *N*-acetyl aspartate (NAA) and glutamate / glutamine. We hypothesize that the alteration exists in the individuals with a high genetic risk of schizophrenia and the alteration would be associated with their genetic loading.

**Methods:** The concentration of brain metabolites in the anterior cingulate cortex, left dorsolateral prefrontal cortex, left thalamus was acquired using ^1^H-MRS at 3 Tesla from 24 participants. The participants comprise of 12 high genetic risk group, who had at least two relatives with schizophrenia and 12 age- and gender- matched controls. We assessed the association between brain metabolite concentration and the genetic loading.

**Results:** Compared to healthy controls, the high genetic risk group demonstrated increment in glutamate / glutamine concentrations in anterior cingulate cortex and thalamus. The NAA level was significantly increased in the thalamus. The increased level of the glutamate / glutamine was significantly correlated with the individual's genetic loadings.

**Discussion:** Our results suggest that the high genetic risk group demonstrates the similar pattern of alterations in glutamate / glutamine level with those observed in schizophrenia. However, in contrary to previous schizophrenia studies, NAA level was increased suggesting that the compensatory neuroplasticity mechanism may exist in the high genetic risk group. The altered glutamate / glutamine level at the thalamus was correlated with the individual's genetic loading, suggesting that the aberrant brain metabolite at the thalamus could be considered as a genetic vulnerability marker.
